NCT03489304View on ClinicalTrials.gov

Zaleplon in HIV Patients With Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 3, 2014

Primary Completion Date

February 4, 2015

Study Completion Date

February 4, 2015

Conditions
HIV/AIDSClinical Depression
Interventions
DRUG

Zaleplon

non-benzodiazepine hypnotic agent

Trial Locations (1)

29615

Mood & Anxiety Disorders Research and Treatment Program, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT03489304 - Zaleplon in HIV Patients With Depression | Biotech Hunter | Biotech Hunter